FIELD: pharmaceutics.
SUBSTANCE: invention relates to an agent possessing immunomodulatory and antiviral action. Agent having immunomodulatory and antiviral action in form of an ointment, which contains medical vaseline, anhydrous lanolin, peach oil, alpha-tocopherol acetate, human recombinant interferon alpha-2b, ascorbic acid, human serum albumin solution 10 %, calcium pantothenate, purified water, taken in a certain amount.
EFFECT: said agent possesses pronounced immunomodulatory and antiviral action, is stable during storage.
1 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINE WITH IMMUNE MODIFYING, ANTIVIRUS, ANTIBACTERIAL ANTIOXIDISING, MEMBRANE STABILISING, CARTILAGE AND CONNECTIVE TISSUE GROWTH STIMULATING EFFECT | 2007 |
|
RU2349339C1 |
| CURATIVE AGENT | 2005 |
|
RU2283133C1 |
| MEDICINAL PRODUCT BASED ON INTERFERON ALFA-2B HUMAN RECOMBINANT METHIONINE-FREE | 2022 |
|
RU2795854C1 |
| OINTMENT | 1995 |
|
RU2114611C1 |
| IMMUNOMODULATING, ANTIVIRAL, ANTIBACTERIAL, ANTIOXIDATING, MEMBRANE STABILISING, ANTI-INFLAMMATORY, ANTITOXIC MEDICINAL AGENT FOR INFLAMMATORY-INFECTIOUS DISEASES | 2007 |
|
RU2327486C1 |
| HYPOALLERGENIC MEDICINAL AGENT APPLIED FOR TREATMENT OF INFECTION-INFLAMMATORY DISEASES OF DIFFERENT AETIOLOGY | 2007 |
|
RU2326688C1 |
| PROLONGED INTERFERON SOLUTION | 2004 |
|
RU2270692C1 |
| IMMUNOCORRECTIVE AGENT FOR TREATING DISEASES OF VIRAL AETIOLOGY | 2007 |
|
RU2411039C2 |
| AGENT FOR SEVERE INFECTIOUS DISEASES AND MIXED INFECTIONS | 2008 |
|
RU2366450C1 |
| PHARAMCEUTICAL AGENT FOR TREATMENT OF VIRAL AND DIFFERENT INFECTIONS | 2006 |
|
RU2323738C1 |
